Evidence map›Paper›PMID 32376733›Full record

ArticleThorax2020

Frailty after lung transplantation is associated with impaired health-related quality of life and mortality.

Aida Venado, Nicholas A Kolaitis, Chiung-Yu Huang, Ying Gao, David V Glidden, Allison Soong, Nicole Sutter, Patricia P Katz, John R Greenland, Daniel R Calabrese and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Thorax, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Timing of quality of life and lung function changes during the first year following lung transplantation: A multicenter prospective cohort study.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2026
    Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Cellular Senescence and Frailty in Transplantation.Current transplantation reports · 2023
    Article
  18. Article
  19. Subphenotypes of frailty in lung transplant candidates.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 2 institutions in 1 country.

Aida VenadoMedicine, University of California San Francisco, San Francisco, California, USA aida.venado@ucsf.edu.ORCID 0000-0001-6791-1763
Nicholas A KolaitisMedicine, University of California San Francisco, San Francisco, California, USA.
Chiung-Yu HuangEpidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
Ying GaoMedicine, University of California San Francisco, San Francisco, California, USA.
David V GliddenEpidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
Allison SoongMedicine, University of California San Francisco, San Francisco, California, USA.
Nicole SutterMedicine, University of California San Francisco, San Francisco, California, USA.
Patricia P KatzMedicine, University of California San Francisco, San Francisco, California, USA.
John R GreenlandMedicine, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0003-1422-8367
Daniel R CalabreseMedicine, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-0596-3434
Steven R HaysMedicine, University of California San Francisco, San Francisco, California, USA.
Jeffrey A GoldenMedicine, University of California San Francisco, San Francisco, California, USA.
Rupal J ShahMedicine, University of California San Francisco, San Francisco, California, USA.
Lorriana E LeardMedicine, University of California San Francisco, San Francisco, California, USA.
Jasleen KukrejaSurgery, University of California San Francisco, San Francisco, California, USA.
Tobias DeuseSurgery, University of California San Francisco, San Francisco, California, USA.
Paul J WoltersMedicine, University of California San Francisco, San Francisco, California, USA.
Kenneth CovinskyMedicine, University of California San Francisco, San Francisco, California, USA.
Paul D BlancMedicine, University of California San Francisco, San Francisco, California, USA.
Jonathan P SingerMedicine, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0003-0224-7472
University of California, San Francisco · USSan Francisco VA Medical Center · US

Funding

Frailty and patient centered outcomes in candidates for lung transplantationR01HL134851 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SINGER, JONATHAN PAUL · 2017 to 2021
$3.4M
Telomere Dysfunction as a cause of Chronic Lung Allograft DysfunctionR01HL151552 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GREENLAND, JOHN · 2020 to 2024
$1.6M
The Effects of Lung Transplant on Disability and Health-Related Quality of LifeK23HL111115 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SINGER, JONATHAN PAUL · 2012 to 2016
$832k
Cytomegalovirus Immune Responses in Chronic Lung Allograft Dysfunction PathogenesisI01CX002011 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI GREENLAND, JOHN · 2020 to 2025
–
Immune Mechanisms of Large-airway Lymphocytic BronchitisIK2CX001034 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI GREENLAND, JOHN · 2015 to 2019
–
CSRD VA I01 CX002011CSRD VA IK2 CX001034NHLBI NIH HHS K23 HL111115NHLBI NIH HHS R01 HL134851NHLBI NIH HHS R01 HL151552
6 · The paper itself

Abstract

backgroundLung transplantation and related medications are associated with pathobiological changes that can induce frailty, a state of decreased physiological reserve. Causes of persistent or emergent frailty after lung transplantation, and whether such transplant-related frailty is associated with key outcomes, are unknown.

methodsFrailty and health-related quality of life (HRQL) were prospectively measured repeatedly for up to 3 years after lung transplantation. Frailty, quantified by the Short Physical Performance Battery (SPPB), was tested as a time-dependent binary and continuous predictor. The association of transplant-related frailty with HRQL and mortality was evaluated using mixed effects and Cox regression models, respectively, adjusting for age, sex, ethnicity, diagnosis, and for body mass index and lung function as time-dependent covariates. We tested the association between measures of body composition, malnutrition, renal dysfunction and immunosuppressants on the development of frailty using mixed effects models with time-dependent predictors and lagged frailty outcomes.

resultsAmong 259 adults (56% male; mean age 55.9±12.3 years), transplant-related frailty was associated with lower HRQL. Frailty was also associated with a 2.5-fold higher mortality risk (HR 2.51; 95% CI 1.21 to 5.23). Further, each 1-point worsening in SPPB was associated, on average, with a 13% higher mortality risk (HR 1.13; 95% CI 1.04 to 1.23). Secondarily, we found that sarcopenia, underweight and obesity, malnutrition, and renal dysfunction were associated with the development of frailty after transplant.

conclusionsTransplant-related frailty is associated with lower HRQL and higher mortality in lung recipients. Abnormal body composition, malnutrition and renal dysfunction may contribute to the development of frailty after transplant. Confirming the role of these potential contributors and developing interventions to mitigate frailty may improve lung transplant success.

Indexed as

Quality of LifeAdultAgedFemaleFollow-Up StudiesFrailtyHumansLung DiseasesLung TransplantationMaleMiddle AgedPostoperative ComplicationsProspective StudiesSurvival Ratelung transplantation

Identifiers

PMID32376733
PMCPMC8023537
OpenAlexW3023555282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.